Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial-Reference-Cited by-同舟云学术

Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): a randomized, double-blind, placebo-controlled phase III trial

Published:2022-09 Issue:9 Volume:33 Page:959-967
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kurokawa Y.,Honma Y.,Sawaki A.,Naito Y.,Iwagami S.,Komatsu Y.,Takahashi T.,Nishida T.,Doi T.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference26 articles.

1. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies;Søreide;Cancer Epidemiol,2016

2. The management of metastatic GIST: current standard and investigational therapeutics;Kelly;J Hematol Oncol,2021

3. Gastrointestinal stromal tumour;Rubin;Lancet,2007

4. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Engl J Med,2002

5. Secondary KIT mutations: the GIST of drug resistance and sensitivity;Napolitano;Br J Cancer,2019

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perihematomal Neurovascular Protection: Blocking HSP90 Reduces Blood Infiltration Associated with Inflammatory Effects Following Intracerebral Hemorrhage in Rates;Translational Stroke Research;2024-09-04

2. An update on the status of HSP90 inhibitors in cancer clinical trials;Cell Stress and Chaperones;2024-08

3. Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors;BJC Reports;2024-07-25

4. Cardiovascular safety of pimitespib in patients with advanced solid tumors: An open‐label, nonrandomized, phase 1 study;Cancer;2024-07-10

5. Comprehensive analysis of resorcinyl-imidazole Hsp90 inhibitor design;European Journal of Medicinal Chemistry;2024-07